Search
for
Sort by
Research 331–360 of 471
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Platelet-rich plasma: The journey so far !
- Psychosocial and mental impact of alopecia areata: Analysis of the Danish Skin Cohort
- Validation of an Egyptian Arabic Version of Skindex-16 and Quality of Life Measurement in Egyptian Patients with Skin Disease
- Nutritional and Microbial Strategies for Treating Acne, Alopecia, and Atopic Dermatitis
- Health‐related quality of life (hrQoL) among patients with primary cicatricial alopecia (PCA): A systematic review
- Under Development JAK Inhibitors for Dermatologic Diseases
- Trichoscopic Signs in Dermatomyositis, Systemic Lupus Erythematosus, and Systemic Sclerosis: A Comparative Study of 150 Patients
- Comparative Analysis of the Cutaneous Microbiome in Psoriasis Patients and Healthy Individuals—Insights into Microbial Dysbiosis: Final Results
- Development of the Alopecia Areata Patient Priority Outcomes Instrument: A Qualitative Study
- Prospective randomized study of sexual function in men taking dutasteride for the treatment of androgenetic alopecia
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity
- Alexithymia and Cutaneous Disease Morbidity: A Systematic Review
- Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam For Scalp Psoriasis
- Beyond health-related quality of life: initial psychometric validation of a new scale for addressing the gap in assessing the full range of alopecia areata psychosocial burden
- Measuring Patient Quality of Life Following Treatment for Alopecia
- Evaluation of quality of life scores and family impact scales in pediatric patients with alopecia areata: a cross‐sectional cohort study
- The Efficacy and Psychoneuroimmunology Mechanism of Camouflage Combined With Psychotherapy in Vitiligo Treatment
- Refractory dissecting cellulitis of the scalp treated with risankizumab: 2 case reports
- Serum brain‐derived neurotrophic factor and vitamin D: Two concordant players controlling depression among alopecia areata and vitiligo patients: A case–control study
- The Role of Hormones in Hidradenitis Suppurativa: A Systematic Review
- Lichen Planus Activity and Damage Index (LiPADI)–Creation of the Questionnaire
- Dermatological concerns for women and girls with turner syndrome
- The Hairdex Quality of Life Instrument—A Translation and Psychometric Validation in Patients with Alopecia Areata
- Quality of Life and Mood Status Disturbances in Cohabitants of Patients with Alopecia Areata: A Cross-Sectional Study in a Spanish Population
- Off-Label Use of Botulinum Toxin in Dermatology—Current State of the Art
- Lack of association between atopic dermatitis severity and worsening during pregnancy: A cross-sectional study